ZS PHARMA
ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. Its core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. The company'ss therapeutic candidate, ZS-9, is a novel treatment for hyperkalemia, a life-threatening condition that affects patients with chronic kidney disease, hypertension, diabetes, and/or chronic heart failure. Hyperkalemia is characterized by abnormally high concentrations of potassium in the blood. ZS-9 is currently being tested in late-stage clinical trials.
ZS PHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2008-01-01
Address:
Coppell, Texas, United States
Country:
United States
Website Url:
http://www.zspharma.com
Total Employee:
51+
Status:
Closed
Contact:
877-700-0240
Email Addresses:
[email protected]
Total Funding:
128.29 M USD
Technology used in webpage:
Google Maps Amazon GStatic Google Static Content Google Maps API ASP.NET Rackspace CDN
Similar Organizations
Amplyx Pharmaceuticals
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
F2G
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Inozyme
Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially.
Pharmaca
Pharmaca offers traditional pharmacy services as well as holistic remedies, providing over-the-counter medicines and alternative remedies.
PharmaEssentia
PharmaEssentia develops treatments for myeloproliferative neoplasms, hepatitis and other diseases.
Ra Pharmaceuticals
Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Venatorx Pharmaceuticals
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
RiverVest
RiverVest investment in Series D - ZS Pharma
Salem Partners
Salem Partners investment in Series D - ZS Pharma
Adage Capital Management
Adage Capital Management investment in Series D - ZS Pharma
Devon Park BioVentures
Devon Park BioVentures investment in Series D - ZS Pharma
Alta Partners
Alta Partners investment in Series D - ZS Pharma
3x5 Special Opportunity Fund
3x5 Special Opportunity Fund investment in Series D - ZS Pharma
Novo Holdings
Novo Holdings investment in Series D - ZS Pharma
Sofinnova Investments
Sofinnova Investments investment in Series D - ZS Pharma
RA Capital Management
RA Capital Management investment in Series D - ZS Pharma
Partisan Management Group
Partisan Management Group investment in Series C - ZS Pharma
Official Site Inspections
http://www.zspharma.com
- Host name: ec2-100-28-104-175.compute-1.amazonaws.com
- IP address: 100.28.104.175
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "ZS Pharma"
ZS Pharma, Inc. | LinkedIn
ZS Pharma, Inc. | 4,935 followers on LinkedIn. From manufacturing to technology to people, ZS Pharma is thinking differently about developing therapies to address unmet needs. ZS Pharma …See details»
ZS Pharma Company Profile 2024: Valuation, Investors ... - PitchBook
ZS Pharma General Information Description. Operator of a biopharmaceutical company. The company is focused on the development and commercialization of highly selective, non …See details»
ZS PHARMA, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ZS PHARMA, INC. of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»
ZS Pharma - Crunchbase Company Profile & Funding
ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. Its core focus is the research and development of highly selective ion-trap …See details»
ZS Pharma - Overview, News & Similar companies | ZoomInfo.com
Who is ZS Pharma. ZS Pharma is using innovative technology to change the landscape of disease management. ZS Pharma was founded in 2008, became a public company in 2 014 …See details»
ZS Pharma - Products, Competitors, Financials, Employees, …
About ZS Pharma. ZS Pharma is a specialty pharmaceutical company focused on the development and commercialization of oral sorbent technology. The company's lead …See details»
ZS Pharma - Funding, Financials, Valuation & Investors - Crunchbase
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.See details»
ZS Pharma - VentureRadar
"Founded in 2008, ZS Pharma, Inc. is a privately held specialty pharmaceutical company located in Fort Worth, Texas. It is focused on the development and commercialization of proprietary …See details»
AstraZeneca acquires ZS Pharma in $2.7 billion deal | AP News
Nov 6, 2015 The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, …See details»
Emerging biopharma solutions: Preclinical to commercial launch - ZS
Sep 26, 2024 Expand your reach and elevate your impact. We empower commercial-stage biopharma companies to grow as they navigate international markets, expand into new areas, …See details»
AstraZeneca completes acquisition of ZS Pharma
17 December 2015. AstraZeneca announced today the successful completion of the tender offer for all of the outstanding shares of ZS Pharma (NASDAQ: ZSPH) and the subsequent …See details»
AstraZeneca Acquires ZS Pharma - Pharmacy Times
Nov 6, 2015 AstraZeneca has entered into a definitive agreement to acquire ZS Pharma, a biopharmaceutical company based in San Mateo, California.See details»
AstraZeneca agrees to acquire ZS Pharma for $2.7bn
Nov 8, 2015 ZS Pharma chief executive officer Robert Alexander said: "This agreement will allow us to maximise the potential of ZS-9, drawing on AstraZeneca’s long-standing expertise …See details»
Working at ZS Pharma - Glassdoor
ZS Pharma was founded in 2008, became a public company in 2014 and, in December 2015, joined the AstraZeneca Group. ZS Pharma is a biopharmaceutical company with offices in …See details»
ZS Pharma, Inc. Careers and Employment | Indeed.com
Find out what works well at ZS Pharma, Inc. from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and …See details»
ZS PHARMA INC Company Profile | Fort Worth, TX | Competitors ...
Find company research, competitor information, contact details & financial data for ZS PHARMA INC of Fort Worth, TX. Get the latest business insights from Dun & Bradstreet.See details»
What is ZS Pharma? Company Culture, Mission, Values
See what employees say it's like to work at ZS Pharma. Salaries, reviews, and more - all posted by employees working at ZS Pharma.See details»
Pharma and biotech consulting and solution firm | ZS
Sep 26, 2024 Increase your commercial organization’s efficiency and effectiveness with smarter sales strategies, team structures and performance management solutions. Learn more. …See details»
AstraZeneca to Acquire ZS Pharma for $2.7B - genengnews.com
Nov 6, 2015 AstraZeneca said today it will acquire ZS Pharma for approximately $2.7 billion, in a deal designed to expand the buyer’s cardiovascular and metabolic disease portfolio.See details»
Biotech and life sciences consulting - ZS
Sep 26, 2024 In the continuously evolving healthcare industry, we connect the dots across your organization, from R&D through commercialization, delivering solutions for your most difficult …See details»